628 related articles for article (PubMed ID: 25731981)
1. Action mechanism of 6, 6'-dihydroxythiobinupharidine from Nuphar japonicum, which showed anti-MRSA and anti-VRE activities.
Okamura S; Nishiyama E; Yamazaki T; Otsuka N; Taniguchi S; Ogawa W; Hatano T; Tsuchiya T; Kuroda T
Biochim Biophys Acta; 2015 Jun; 1850(6):1245-52. PubMed ID: 25731981
[TBL] [Abstract][Full Text] [Related]
2. [Search for Novel Antibacterial Compounds and Targets].
Kuroda T; Ogawa W
Yakugaku Zasshi; 2017; 137(4):383-388. PubMed ID: 28381710
[TBL] [Abstract][Full Text] [Related]
3. An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.
Tiz DB; Skok Ž; Durcik M; Tomašič T; Mašič LP; Ilaš J; Zega A; Draskovits G; Révész T; Nyerges Á; Pál C; Cruz CD; Tammela P; Žigon D; Kikelj D; Zidar N
Eur J Med Chem; 2019 Apr; 167():269-290. PubMed ID: 30776691
[TBL] [Abstract][Full Text] [Related]
4. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
Cheng J; Thanassi JA; Thoma CL; Bradbury BJ; Deshpande M; Pucci MJ
Antimicrob Agents Chemother; 2007 Jul; 51(7):2445-53. PubMed ID: 17502409
[TBL] [Abstract][Full Text] [Related]
5. Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines.
Werner MM; Patel BA; Talele TT; Ashby CR; Li Z; Zauhar RJ
Bioorg Med Chem; 2015 Sep; 23(18):6125-37. PubMed ID: 26320664
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of phytochemicals isolated from Erythrina zeyheri against vancomycin-resistant enterococci and their combinations with vancomycin.
Sato M; Tanaka H; Oh-Uchi T; Fukai T; Etoh H; Yamaguchi R
Phytother Res; 2004 Nov; 18(11):906-10. PubMed ID: 15597305
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
Wang Z; Cao B; Liu YM; Gu L; Wang C
Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of actinomycins from Streptomyces strain M7 active against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus.
Sharma M; Manhas RK
BMC Microbiol; 2019 Feb; 19(1):44. PubMed ID: 30782119
[TBL] [Abstract][Full Text] [Related]
10. [In vitro activity of daptomycin against VRE and MRSA strains].
Aktaş G; Derbentli S
Mikrobiyol Bul; 2014 Jan; 48(1):123-8. PubMed ID: 24506722
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel 2-aminobenzothiazole derivatives as potential antimicrobial agents with dual DNA gyrase/topoisomerase IV inhibition.
Ismail MMF; Abdulwahab HG; Nossier ES; El Menofy NG; Abdelkhalek BA
Bioorg Chem; 2020 Jan; 94():103437. PubMed ID: 31812260
[TBL] [Abstract][Full Text] [Related]
12. 6,6'-Dihydroxythiobinupharidine (DTBN) Purified from
Waidha K; Anto NP; Jayaram DR; Golan-Goldhirsh A; Rajendran S; Livneh E; Gopas J
Molecules; 2021 May; 26(9):. PubMed ID: 34066895
[TBL] [Abstract][Full Text] [Related]
13. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
Hossion AM; Zamami Y; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Sasaki K
J Med Chem; 2011 Jun; 54(11):3686-703. PubMed ID: 21534606
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of Australian plant extracts against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
Palombo EA; Semple SJ
J Basic Microbiol; 2002; 42(6):444-8. PubMed ID: 12442307
[TBL] [Abstract][Full Text] [Related]
15. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
[TBL] [Abstract][Full Text] [Related]
16. In Vitro and In Vivo Therapeutic Potential of 6,6'-Dihydroxythiobinupharidine (DTBN) from
Weiss S; Waidha K; Rajendran S; Benharroch D; Khalilia J; Levy H; Bar-David E; Golan-Goldhirsh A; Gopas J; Ben-Shmuel A
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176034
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of alpha-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics.
Sakagami Y; Iinuma M; Piyasena KG; Dharmaratne HR
Phytomedicine; 2005 Mar; 12(3):203-8. PubMed ID: 15830842
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
Hossion AM; Otsuka N; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Zamami Y; Sasaki K
Bioorg Med Chem Lett; 2010 Sep; 20(17):5349-52. PubMed ID: 20655215
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of stilbene oligomers against vancomycin-resistant Enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) and their synergism with antibiotics.
Sakagami Y; Sawabe A; Komemushi S; All Z; Tanaka T; Iliya I; Iinuma M
Biocontrol Sci; 2007 Mar; 12(1):7-14. PubMed ID: 17408003
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activities of hydrophobic 2-arylbenzofurans and an isoflavone against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.
Fukai T; Oku Y; Hano Y; Terada S
Planta Med; 2004 Jul; 70(7):685-7. PubMed ID: 15303263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
